Brief: Vaccitech Announces Notification Of Milestone And Royalty Revenue Relating To Sales Of Vaxzevria
April 6 (Reuters) - Vaccitech PLC VACC.O :
* VACCITECH ANNOUNCES NOTIFICATION OF MILESTONE AND ROYALTY
REVENUE RELATING TO SALES OF VAXZEVRIA®
* VACCITECH PLC - CO'S SHARE OF MILESTONE & ROYALTY
PAYMENTS, FROM
ASTRAZENECA'S COMMERCIAL SALES OF VAXZEVRIA IN Q4 2021, AMOUNTS
TO ABOUT $15 MILLION
Source text for Eikon: ID:nGNX3FwtXL
Further company coverage: VACC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing